9780671510572-0671510576-The Billion Dollar Molecule: One Company's Quest for the Perfect Drug

The Billion Dollar Molecule: One Company's Quest for the Perfect Drug

ISBN-13: 9780671510572
ISBN-10: 0671510576
Edition: Reprint
Author: Barry Werth
Publication date: 1995
Publisher: Simon & Schuster
Format: Paperback 464 pages
FREE US shipping on ALL non-marketplace orders
Marketplace
from $17.02 USD
Buy

From $17.02

Book details

ISBN-13: 9780671510572
ISBN-10: 0671510576
Edition: Reprint
Author: Barry Werth
Publication date: 1995
Publisher: Simon & Schuster
Format: Paperback 464 pages

Summary

The Billion Dollar Molecule: One Company's Quest for the Perfect Drug (ISBN-13: 9780671510572 and ISBN-10: 0671510576), written by authors Barry Werth, was published by Simon & Schuster in 1995. With an overall rating of 4.2 stars, it's a notable title among other Company Profiles (Biography & History, Pharmaceutical & Biotechnology, Industries, Biotechnology, Biological Sciences, Molecular Chemistry, Chemistry, Pharmacy, Pharmacology) books. You can easily purchase or rent The Billion Dollar Molecule: One Company's Quest for the Perfect Drug (Paperback) from BooksRun, along with many other new and used Company Profiles books and textbooks. And, if you're looking to sell your copy, our current buyback offer is $0.54.

Description

Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing -- atom by atom -- both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS.
You will be hooked from start to finish, as you go from the labs, where obsessive, fiercely competitive scientists struggle for a breakthrough, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts investors and finally decides to take Vertex public. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS.

Rate this book Rate this book

We would LOVE it if you could help us and other readers by reviewing the book